Imprimed

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Health and bioPlug and PlayPear VC

Latest funding

Series A · December 19, 2023

Amount not disclosed in a source on record.

All 3 rounds ↓

Website: imprimedicine.com.

X: @Imprimedicine · 55 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Animal Health, Health & Longevity.

Stage: Series A.

Based in: United States.

Last round: Dec 19, 2023 · 1,059 days ago.

On Recent Funding since: Sep 28, 2026.

Signals

X account@Imprimedicine · created Nov 4, 2020 (6 years old) · 55 followers

Website registeredJan 30, 2016 (10 years old)

Funding rounds

December 19, 2023
Series A · amount undisclosed
Source: fundraisingfox.com
November 4, 2020
X account created
January 30, 2016
Website created
Date unknown
PPlug and Play · accelerator or program
Source: public.dxp.playbook.vc
Date unknown
PPear VC · accelerator or program
Source: pear.vc

Founders and team

HR
Hye Ryeon Lee Founder
JK
Jamin Koo Founder

LinkedIn · source: imprimedicine.com
SL
Sungwon Lim Founder

source: imprimedicine.com
VG
Valerie Goodwin-Adams Chief Commercial Officer

Investors

Companies like Imprimed

GGreatly Health$4M Seed · Apr 2026
MMindpeak$15.3M Series A · Oct 2024
PPURMX Therapeutics
AAntheia$24M Series B+ · Jan 2026
BBridgeHealth PharmaceuticalsSeed · Nov 2026
LLoyalSeries B+ · Mar 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/imprimed (get a free API key).